Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

A Phase 3 Study of I-DXd in Subjects with Relapsed SCLC Recruiting

2023-509628-16-00 Small Cell Lung Cancer (SCLC) 5 2026-05-07
Single arm phase 2 trial of neoadjuvant trastuzumab deruxtecan (T-DXd) with response-directed definitive therapy in early stage HER2-positiv… Recruiting

2024-516582-36-00 Early stage HER2-positive breast cancer 10 2026-05-01
Dual-Wavelength Quantitative Fluorescence Endoscopy for Optical PD-1 and PD-L1 Imaging in Locally Advanced Esophageal Cancer: A Phase I Mult… Recruiting

2024-520090-12-00 Esophageal cancer 1 2026-05-01
A study in people with advanced cancer to test how well different doses of BI 3819026 are tolerated when taken alone and together with ezabe… Recruiting

2025-522953-21-00 unresectable advanced or metastatic solid cancer 3 2026-04-30
A study to compare Venetoclax Azacitidine and Quizartinib Vs Venetoclax and Azacitidine in newly diagnosed acute myeloid leukemia patient´s … Recruiting

2025-522979-29-00 Acute myeloid leukemia 5 2026-04-30
Pembro-FLASH Recruiting

2022-501458-13-01 Advanced Stage of Classic Hodgkin Lymphoma 4 2026-04-29
A Phase 1 Study to Assess Radiation Biodistribution, Dosimetry, Pharmacokinetics and Safety of GEH300079 (68Ga) Injection and Determine the … Recruiting

2025-522541-21-00 Peritoneal Carcinomatosis of Colorectal,Gastric, Pancre 3 2026-04-28
Phase 1/2A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients with Advanced Solid Tumors Recruiting

2025-524111-37-00 advanced solid tumors 7 2026-04-28
A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BGB-B2033,… Recruiting

2025-524136-19-00 Selected Advanced or Metastatic Solid Tumors 1 2026-04-28
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants with Multiple Myeloma Receiving Etentamig (ABBV-… Recruiting

2024-515770-27-00 Multiple Myeloma 9 2026-04-27
An early Phase 1b Study to assess how safe and effective is the treatment with drugs, called Mosunetuzumab or Glofitamab in Combination with… Recruiting

2023-505185-28-00 Non-Hodgkin Lymphoma 3 2026-04-23
A Single-center, Prospective, Non-randomized, Open, Pilot Study Evaluating the Safety and Performance of the Extroducer® Infusion Catheter S… Recruiting

2025-524733-11-00 Unresectable Locally Advanced Pancreatic Cancer 9 2026-04-22
A clinical trial of sacituzumab tirumotecan to treat urothelial cancer (MK-2870-031) Recruiting

2024-520014-22-00 Locally advanced/metastatic urothelial carcinoma 5 2026-04-22
A clinical study to investigate the efficacy and safety of an investigational combination therapy with BNT324 and BNT327 in patients with ad… Recruiting

2024-520238-31-01 Advanced Lung Cancer 9 2026-04-20
Sodium selenite in patients with advanced carcinoma: SECAR 1c Recruiting

2025-522798-13-00 Advanced carcinoma 9 2026-04-17
Neoadjuvant gemcitabine and cisplatin in combination with perioperative pembrolizumab versus upfront surgery for patients with primary resec… Recruiting

2024-516898-72-00 Perihilar cholangiocarcinoma, distal cholangiocarcinoma 10 2026-04-17
A Phase I Interventional Open-Label, Non-Randomized Dose-Escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacody… Recruiting

2024-516660-28-01 Locally advanced, recurrent, or metastatic breast, gast 1 2026-04-17
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients with Advanced Liver Cancers (M… Recruiting

2023-506611-17-00 Advanced liver cancers 9 2026-04-16
A Phase 1a/1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Antitumor Activity of BG-75202, … Recruiting

2025-523553-34-00 Advanced and Metastatic Solid tumors 1 2026-04-15
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma Recruiting

2025-524542-10-00 Endometrial cancer 4 2026-04-14
A trial to learn how safe the combination of rilvegostomig and chemotherapy is and how well it works compared to durvalumab and chemotherapy… Recruiting

2025-523085-24-00 Biliary Tract Cancer 5 2026-04-13
Study of ART6043 in Advanced/Metastatic Solid Tumors Patients Recruiting

2023-509220-17-00 Metastatic solid tumors 7 2026-04-10
A Phase 1a/1b Open-Label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of BBO-8520 in Subjects with Advanced KRA… Recruiting

2024-512515-45-01 Non-Small Cell Lung Cancer 1 2026-04-10
Study of Pumitamig in Combination with Chemotherapy Versus Nivolumab in Combination with Chemotherapy in Previously Untreated Advanced or Me… Recruiting

2025-523263-37-00 Previously Untreated Advanced or Metastatic Gastric, Ga 10 2026-04-08